20 Years on Wall Street Taught Me: Boomers Feel Safe With 5 High-Yield Dividend Giants

After a 35-year career in the finance industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I developed an institutional perspective on dividend-focused investing.

24/7 Wall Street • 11 hours ago

Kenvue Surges as Earnings Beat, Kimberly-Clark Merger Gains Steam

Kenvue (NYSE: KVUE) reported fourth-quarter results yesterday that exceeded analyst expectations, with adjusted EPS of $0.27 beating the FactSet estimate of $0.22 by 23%.

24/7 Wall Street • Feb 18, 2026

Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations

On Feb. 18, 2026, investors weighed Kenvue's earnings momentum against looming merger costs and related risks.

The Motley Fool • Feb 18, 2026

Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal

KVUE reports solid Q4 results, with margin gains and broad-based global growth, while moving closer to its planned Kimberly-Clark acquisition.

Zacks Investment Research • Feb 18, 2026

Kenvue tops Q4 forecasts as Kimberly-Clark deal advances

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring steps ahead of its planned combination with Kimberly-Clark. For Q4, Kenvue posted adjusted earnings per share of $0.27, beating analyst estimates of $0.22.

Proactive Investors • Feb 18, 2026

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

The job cuts are part of a restructuring plan to optimize its operating model and drive operational efficiencies, the company said.

WSJ • Feb 17, 2026

Kenvue Reports Fourth Quarter and Full Year 2025 Results

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal fourth quarter and full year ended December 28, 2025. “We ended 2025 with stronger top- and bottom-line performance in the fourth quarter, which reflected both disciplined execution against our strategic priorities, as well as a more favorable year-ago comparison on sales,” said Kirk Perry, Chief Executive Officer. “As we look to 2026, we remain focused on continuing to enhance our performan.

Business Wire • Feb 17, 2026

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

Tylenol-maker Kenvue on Tuesday beat Wall Street estimates for fourth-quarter results and announced a global workforce reduction, as it proceeds toward a planned takeover by Kimberly-Clark.

Reuters • Feb 17, 2026

Kenvue (KVUE) Beats Q4 Earnings and Revenue Estimates

Kenvue (KVUE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.26 per share a year ago.

Zacks Investment Research • Feb 18, 2026

Dividend Kings: No Ideal Buys In February's 57

Dividend Kings remain broadly overvalued, with only a handful approaching fair price despite elevated yields. Three Dividend Kings—Canadian Utilities, Fortis, and Hormel—currently meet the dogcatcher 'ideal' but face dividend safety concerns due to negative free cash flow margins. Analyst projections estimate 14.16% to 27.77% net gains for top-yielding Dividend Kings by February 2027, with ABBV and NWN ranking in the top 20 across yield, target, and returns.

Seeking Alpha • Feb 10, 2026